ONCOtherapeutics, founded in 2002, is a strategic Contract Research Organization (CRO) based in the United States, specializing in community-based hematology & oncology research. The company offers a full suite of services, including expert dedicated project teams, medical writing, data management, analysis and reporting, as well as regulatory submissions.
The company’s unique focus on community-based sites allows them to provide real-world experience, data, and outcomes, ultimately leading to improved clinical utility of cancer therapies, and thus, improving the lives of cancer patients. They boast nationally recognized research oncologists and Key Opinion Leaders in the oncology field, who work in parallel with their senior level clinical research teams.
ONCOtherapeutics has a strong track record of short start-up times and adherence to enrollment and completion timelines. Their history of client satisfaction and success stands as testament to their commitment to their clients.
As of now, there is no publicly available information regarding the last investment or the last investment investors in this organization.